Key result
Remote dielectric sensing reliably quantifies pulmonary congestion, but clinical outcome benefits remain preliminary.
Why the study?
Pulmonary congestion is a major determinant of outcomes in cardiovascular disease, yet its quantitative assessment remains challenging.
Does remote dielectric sensing (ReDS) accurately assess pulmonary congestion and improve clinical management or outcomes in patients with cardiovascular disease?
Does remote dielectric sensing (ReDS) accurately assess pulmonary congestion and improve clinical management or outcomes in patients with cardiovascular disease?
Remote dielectric sensing provides a rapid, non-invasive, and quantitative adjunctive measure for evaluating pulmonary congestion, though adequately powered randomized trials are still needed to confirm its impact on clinical outcomes.
Answers are grounded in this paper and cite their sources.
ReDS may complement congestion assessment in heart failure; leaves open outcome benefit from guided therapy pending larger trials.
Pulmonary congestion is a major determinant of symptoms, hospitalization, and prognosis in cardiovascular disease, yet its quantitative assessment remains challenging. Remote dielectric sensing is a non-invasive electromagnetic method that provides a quantitative estimate of pulmonary fluid content within ∼1 min. This narrative review summarizes the principles, validation, clinical interpretation, applications, and limitations of remote dielectric sensing. In a validation study of 46 hospitalized patients, including 28 with heart failure, remote dielectric sensing correlated with computed tomography-derived high-attenuation lung area (r = 0.65, P < .001). In a prospective study of 153 patients with heart failure, remote dielectric sensing correlated with lung ultrasound B-line count (r = 0.544); a threshold of 34.5% identified lung ultrasound-defined pulmonary congestion with an area under the curve of 0.748, sensitivity of 73.5%, and specificity of 70.2%. In 133 patients hospitalized with acute heart failure, with a median age of 78 years, 59% men, and a median left ventricular ejection fraction of 57%, an increase in remote dielectric sensing from admission to discharge was associated with all-cause death or heart failure rehospitalisation (adjusted hazard ratio 4.37, 95% confidence interval 1.13-16.81). In a proof-of-concept randomized trial of 100 patients hospitalized with acute decompensated heart failure, the primary endpoint occurred in 2% with remote dielectric sensing-guided care vs 20% with routine care (hazard ratio 0.094). Available evidence supports diagnostic validity and potential prognostic value, but external validation remains limited. Evidence that remote dielectric sensing-guided management improves clinical outcomes remains preliminary. Remote dielectric sensing should be considered a complementary component of multimodality congestion assessment.
No takes yet. Share an insight, caveat, or question.
Teruhiko Imamura (2026) conducted a review in Pulmonary congestion in cardiovascular disease and heart failure. Remote dielectric sensing (ReDS) was evaluated. Remote dielectric sensing provides non-invasive quantitative estimates of pulmonary fluid with diagnostic and prognostic value, though evidence for improving outcomes remains preliminary.
Synapse has enriched 10 related papers. Consider them for comparative context: